Kenvue Inc. (BMV:KVUE)

Market Cap	567.72B
Revenue (ttm)	275.44B
Net Income (ttm)	26.30B
Shares Out	n/a
EPS (ttm)	13.72
PE Ratio	21.58
Forward PE	14.90
Dividend	15.85 (5.30%)
Ex-Dividend Date	Nov 12, 2025

Volume	18
Average Volume	25,541
Open	299.33
Previous Close	299.33
Day's Range	299.33 - 299.33
52-Week Range	259.01 - 439.23
Beta	n/a
RSI	49.95
Earnings Date	Nov 6, 2025

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2022
• Employees: 22,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: KVUE

Financial Performance

In 2024, Kenvue's revenue was $15.46 billion, an increase of 0.07% compared to the previous year's $15.44 billion. Earnings were $1.03 billion, a decrease of -38.10%.

Financial numbers in USD